Strata Skin Sciences Inc (SSKN)
OTHER OTC:SSKN
Total Valuation
Strata Skin Sciences has a market cap or net worth of $1.12M. The enterprise value is $9.24M.
Market Cap$1.12M
Enterprise Value$9.24M
Share Statistics
Strata Skin Sciences has 5,888,199 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,888,199
Owned by Insiders2.92%
Owned by Institutions16.49%
Financial Efficiency
Strata Skin Sciences’s return on equity (ROE) is -2.15 and return on invested capital (ROIC) is -30.14%.
Return on Equity (ROE)-2.15
Return on Assets (ROA)-0.21
Return on Invested Capital (ROIC)-30.14%
Return on Capital Employed (ROCE)-1.54
Revenue Per Employee289.58K
Profits Per Employee-59.07K
Employee Count106
Asset Turnover1.01
Inventory Turnover4.55
Valuation Ratios
The current PE Ratio of Strata Skin Sciences is ―. Strata Skin Sciences’s PEG ratio is -0.02.
PE Ratio―
PS Ratio1.91
PB Ratio20.15
Price to Fair Value20.15
Price to FCF-13.75
Price to Operating Cash Flow-0.40
PEG Ratio-0.02
Income Statement
In the last 12 months, Strata Skin Sciences had revenue of 30.70M and earned -6.26M in profits. Earnings per share was -1.35.
Revenue30.70M
Gross Profit17.88M
Operating Income-5.83M
Pretax Income-6.25M
Net Income-6.26M
EBITDA-1.37M
Earnings Per Share (EPS)-1.35
Cash Flow
In the last 12 months, operating cash flow was -2.79M and capital expenditures -1.47M, giving a free cash flow of -4.26M billion.
Operating Cash Flow-2.79M
Free Cash Flow-4.26M
Free Cash Flow per Share-0.72
Dividends & Yields
Strata Skin Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.03
52-Week Price Change-92.83%
50-Day Moving Average0.54
200-Day Moving Average1.46
Relative Strength Index (RSI)31.95
Average Volume (3m)7.72M
Important Dates
Strata Skin Sciences upcoming earnings date is May 20, 2026, After Close (Confirmed).
Last Earnings DateMar 24, 2026
Next Earnings DateMay 20, 2026
Ex-Dividend Date―
Financial Position
Strata Skin Sciences as a current ratio of 0.58, with Debt / Equity ratio of 559.42%
Current Ratio0.58
Quick Ratio0.48
Debt to Market Cap0.27
Net Debt to EBITDA-6.11
Interest Coverage Ratio-2.98
Taxes
In the past 12 months, Strata Skin Sciences has paid 12.00K in taxes.
Income Tax12.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Strata Skin Sciences EV to EBITDA ratio is -48.94, with an EV/FCF ratio of -15.71.
EV to Sales2.18
EV to EBITDA-48.94
EV to Free Cash Flow-15.71
EV to Operating Cash Flow-23.96
Balance Sheet
Strata Skin Sciences has $7.91M in cash and marketable securities with $16.27M in debt, giving a net cash position of -$8.36M billion.
Cash & Marketable Securities$7.91M
Total Debt$16.27M
Net Cash-$8.36M
Net Cash Per Share-$1.42
Tangible Book Value Per Share-$0.04
Margins
Gross margin is 57.83%, with operating margin of -19.01%, and net profit margin of -20.40%.
Gross Margin57.83%
Operating Margin-19.01%
Pretax Margin-20.36%
Net Profit Margin-20.40%
EBITDA Margin-4.46%
EBIT Margin-19.01%
Analyst Forecast
The average price target for Strata Skin Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-5.19%
EPS Growth Forecast-0.81%